Article Details

Alnylam has obesity gene target in its sights - BioPharma-Reporter

Retrieved on: 2022-07-28 17:00:33

Tags for this article:

Click the tags to see associated articles and topics

Alnylam has obesity gene target in its sights - BioPharma-Reporter. View article details on hiswai:

Excerpt

Cambridge, Massachusetts based, Alnylam Pharmaceuticals, along with collaborators, has identified mutations in the INHBE gene linked with ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up